Stephen Liu

5 papers about Lung Cancer suggested by Stephen Liu

Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a few must-read papers on X:

1. “Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study”

Authors: Ziming Li et al.

5 papers about Lung Cancer suggested by Stephen Liu

2. “Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study”

Authors: Ganfeng Luo et al.

5 papers about Lung Cancer suggested by Stephen Liu

3. “Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3”

Authors: Dwight Owen et al.

5 papers about Lung Cancer suggested by Stephen Liu

4. “Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3”

Authors: Natasha Leighl et al.

5 papers about Lung Cancer suggested by Stephen Liu

5. “DESTINY of immunotherapy in HER2 mutant lung cancer patients: case report”

Authors: Lorenza Landi et al.

5 papers about Lung Cancer suggested by Stephen Liu

More posts featuring Stephen Liu.

cancer Dwight Owen Ganfeng Luo Lorenza Landi Lung cancer Mohamed Gouda Natasha Leighl non small cell lung cancer NSCLC OncoDaily Oncology Stephen Liu Ziming Li